Hyperbaric oxygen therapy for treatment of a late presenting ischaemic complication from hyaluronic acid cosmetic filler injection.

What Researchers Did

Researchers presented a case of delayed ischaemic complication from a hyaluronic acid filler injection that was treated with hyaluronidase and hyperbaric oxygen therapy.

What They Found

A patient experienced ischaemic wound and mucosal necrosis within hours of a hyaluronic acid facial injection, but diagnosis and treatment were delayed for 5 days. Treatment included hyaluronidase followed by 14 daily sessions of hyperbaric oxygen therapy (HBOT). Despite the delay, the patient achieved essentially complete recovery.

Canadian Relevance

This case study was authored by Canadian researchers, indicating direct relevance to Canadian medical practice and patient care.

Study Limitations

As a single case report, the findings cannot be generalized to a broader patient population.